Handbook of Solvents - George Wypych - ChemTech - Ventech!

1362 Nachman Brautbar
provide the antigen triggering the immune response, accelerating a cascade of a reaction
ending with glomerulonephritis.
REFERENCES
1 Morrison, RR, and Boyd RN, Organic Chemistry, 5th Edition, Morrison RT, Boyd RN, Eds,
Allyn & Bacon, Boston (1987).
2 Domask, WG, Renal Effects Of Petroleum Hydrocarbons, Mehlman, MA, Hemstreet GP III, Thorpe JJ,
Weaver NK, Eds, Princeton Scientific Publishers, Princeton, 1-25.
3 Pederen, LM., Pharmacol Toxicol, 3, 1-38 (1987).
4 Ervin ME, Clinical Management of Poisoning and Drug Overdose, Addad LM, Winchester JF, Eds,
Saunders, Philadelphia, 771 (1983).
5 Wolfsdorf J, J Pediatr, 88, 1037 (1976).
6 Janssen S, Van der Geest S, Meijer S, and Uges DRA, Intensive Care Med, 14, 238-240 (1988).
7 Smith TC, and Wollman H, The Pharmacological Basis of Therapeutics, Goodman A, Gilman L, Eds,
MacMillan, New York, 260-275 (1985).
8 Clayton GD, and Clayton EE (Eds), Patty’s Industrial Hygiene and Toxicology, Wiley, New York, 26
(1981) and 2C (1982).
9 World Health Organization and Nordic Council of Ministers, Organic Solvents and the Central Nervous
System, Environmental Health 5, Copenhagen and Oslo, 1-135 (1985).
10 Browning E, Toxicity & Metabolism of Industrial Solvents, Elsevier Publishing Company,
Amsterdam-London-New York (1965).
11 Mehlman MA, Hemstreet GP III, Thorpe JJ, and Weaver NK, Series: Advances in Modern Environmental
Toxicology: Volume VII- Renal Effects of Petroleum Hydrocarbons, Princeton Scientific Publishers,
Princeton (1984).
12 Carpenter CP, Geary DL Jr Myers, et al, Toxicol Appl Pharmacol, 41, 251-260 (1977).
13 Gibson JE, and Bus JS, Ann NY Acad Sci, 534, 481-485 (1988).
14 Thomas FB, and Halder CA, Holdsworth CE, Cockrell By, Renal Heterogeneity and Target Cell Toxicity,
Back PH, Lock EA, Eds, Chichester, 477-480 (1985).
15 Halder CA, Van Gorp GS, Hatoum NS, and Warne TM, Am Ind Hyg Assoc J, 47, 164-172 (1986).
16 Coppor, et al, American Journal of Kidney Disease, 12, 420-424 (1988).
17 Emancipator SN, Kidney International, 38, 1216-1229 (1990).
18 Churchill DN, Fina A, and Gault MH, Nephron, 33, 169-172 (1983).
19 Roy AT, Brautbar N, and Lee DBN, Nephron, 58, 385-392 (1991)
20 Sperace GA, Am Rev Resp In Dis, 88, 330-337 (1963).
21 Hele WF, Matthisson Am, and Niall JF, Med J Aust, 355-357 (1969).
22 Klavis G, and Drommer W, Arch Toxicol, 26, 40-50 (1970).
23 Beirne GJ, and Brennan JT, Arch Environ Health, 25, 365-369 (1972).
24 D’Apice AJF, et al, Ann Intern Med, 88, 61-62 (1980).
25 Kleinknecht D, et al, Arch Intern Med, 140, 230-232 (1980).
26 Daniell WE, Couser WG, and Rosenstock L, JAMA, 259, 2280-2283 (1988).
27 Von Scheele C, Althoff P, Kempni V, and Schelin H, Acta Med Scan, 200, 427-429 (1976).
28 Ehrenreicht T, Yunis SL, and Churg J, Environ Res, 24, 35-45 (1977).
29 Cagnoli L, et al, Lancet, 1068-1069 (1980).
30 Brautbar N and Barnett A, Environmental Epidemiology and Toxicology, 2, 163-166 (1999).
31 Lagrue G, et al, J Urol Nephrol, 4-5, 323-329 (1977).
32 Lagrue G, et al, Nouv Press med, 6, 3609-3613 (1977).
33 Bell GM, et al, Nephron, 40, 161-165 (1985).
34 Ravnskov U, Forsbergg B, and Skerfving S, Acta Med Scand, 205, 575-579 (1979).
35 Ravnskov U, Lundstrom S, and Norden A, Lancet, 1214-1216 (1983).
36 Porro A, et al, Br J Ind Med, 49, 738-742 (1992).
37 Yaqoob M, Bell GM, Percy D, and Finn R, Q J Med, 301, 409-418 (1992).
38 Yaqoob M, et al, Diabet Med, 11, 789-793 (1994).
39 Nuyts GD, et al, Lancet, 346, 7-11 (1994).
40 Zimmerman SW, Groehler K, and Beirne GJ, Lancet, 199-201 (1975).
41 Ravnskov U, Acta Med Scand, 203, 351-356 (1978).
42 Finn R, Fennerty RG, and Ahmad R, Clin Nephrol, 14, 173-175 (1980).
43 Van der Laan G, Int Arch Occup Envion Health, 47, 1-8 (1980).